Kathleen M. Langenbacher

Statistics

Publications

Citations

241

H-Index

Active since

1993

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

University Medical Center of Princeton

Clinical Research Associates

Kathleen M. Langenbacher is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, pharmacodynamics, and clinical pharmacology.

Publications per year

1993–1998

Publications

Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.

Andrea A. Seymour, Magdi M. Asaad, V Lanoce et al. · Journal of Pharmacology and Experimental Therapeutics · 1993 · 78 citations

Medicine, Cardiology, Pharmacology +17

Pharmacokinetics and Pharmacodynamics of Irbesartan in Healthy Subjects

Maria Rosaria Marino, Kathleen M. Langenbacher, Neville F. Ford et al. · The Journal of Clinical Pharmacology · 1998 · 72 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Pharmacokinetics and Pharmacodynamics of Irbesartan in Patients with Hepatic Cirrhosis

Maria R. Marino, Kathleen M. Langenbacher, Ralph Raymond et al. · The Journal of Clinical Pharmacology · 1998 · 48 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Effect of Hydrochlorothiazide on the Pharmacokinetics and Pharmacodynamics of the Angiotensin II Blocker Irbesartan

Maria Marino, Kathleen M. Langenbacher, Neville F. Ford et al. · Clinical Drug Investigation · 1997 · 22 citations

Medicine, Pharmacokinetics, Pharmacology +12

The Effect of Nefazodone on the Single-Dose Pharmacokinetics of Phenytoin in Healthy Male Subjects

Maria Rosaria Marino, Kathleen M. Langenbacher, Janis L. Hammett et al. · Journal of Clinical Psychopharmacology · 1997 · 11 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

1–5 of 6